Can a simple blood test tell two forms of a clotting disorder apart?
NCT ID NCT07142239
First seen Jul 30, 2026 · Last updated Jul 31, 2026 · Updated 1 time
Summary
This study looks at three blood markers — mean platelet volume (MPV), platelet-to-lymphocyte ratio (PLR), and neutrophil-to-lymphocyte ratio (NLR) — in people with antiphospholipid syndrome (APS), an autoimmune condition that raises the risk of blood clots and pregnancy complications. Researchers want to see whether these markers differ between primary APS (occurring alone) and secondary APS (occurring with another autoimmune disease like lupus). The goal is to find a simple, inexpensive way to help tell the two forms apart.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If clear differences emerge, these simple blood tests could help doctors distinguish between primary and secondary antiphospholipid syndrome more easily.
- What could go wrong
- This is an observational study, so it cannot prove cause and effect. The markers may not differ enough to be useful in practice.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ANTIPHOSPHOLIPID SYNDROME are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
New Valley University
RECRUITINGAl Khārjah, Kharga Oasis, 72511, Egypt
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Blood platelet trends may reveal hidden risk in autoimmune disease
- Immune clues in the blood may foretell heart trouble
- New fingerstick test for blood thinner monitoring put to the test
- New MRI study seeks hidden stroke causes in rare blood disorder
- New hope for stroke survivors with rare clotting disorder: rivaroxaban vs warfarin
- Could your genes raise your risk for blood clots and miscarriages?